Analysts Set Encompass Health Co. (NYSE:EHC) PT at $107.67

Shares of Encompass Health Co. (NYSE:EHC - Get Free Report) have received a consensus recommendation of "Buy" from the eleven research firms that are covering the company, Marketbeat.com reports. Nine analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month price objective among brokers that have covered the stock in the last year is $107.67.

Several equities research analysts have recently commented on the stock. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp upped their target price on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Finally, Barclays upped their price objective on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th.

Remove Ads

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the firm's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 2.10% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares in the last quarter. Colonial Trust Co SC purchased a new position in shares of Encompass Health during the fourth quarter worth approximately $29,000. Avior Wealth Management LLC purchased a new stake in shares of Encompass Health in the 3rd quarter valued at $40,000. Transce3nd LLC bought a new position in shares of Encompass Health during the fourth quarter valued at about $40,000. Finally, CBIZ Investment Advisory Services LLC grew its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Trading Up 1.5 %

EHC traded up $1.49 during trading on Friday, reaching $99.13. 225,049 shares of the stock traded hands, compared to its average volume of 685,158. The stock's 50-day moving average is $97.60 and its 200 day moving average is $97.05. Encompass Health has a 12 month low of $76.11 and a 12 month high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $9.98 billion, a PE ratio of 22.23, a P/E/G ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities analysts anticipate that Encompass Health will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.69%. The ex-dividend date is Tuesday, April 1st. Encompass Health's dividend payout ratio is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.